Jonathan Carlson's Colleagues at Trevi Therapeutics
Jonathan Carlson's Contact Details
HQ
203-304-2499
203-304-2499
Location
Greater New York City Area
Greater New York City Area
Company
Trevi Therapeutics
Trevi Therapeutics
Jonathan Carlson's Company Details
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.
Frequently Asked Questions about Jonathan Carlson
Jonathan Carlson currently works for Trevi Therapeutics.
Jonathan Carlson's role at Trevi Therapeutics is Senior FP&A Analyst.
Jonathan Carlson's email address is ***@trevitherapeutics.com. To view Jonathan Carlson's full email address, please signup to ConnectPlex.
Jonathan Carlson works in the BioTech/Drugs industry.
Jonathan Carlson's colleagues at Trevi Therapeutics are Pam Nieves, Paula Buckley, Christopher CPA, Rebecca Morse, Christine Ad, Pamela Masella, Danine Summers and others.
Jonathan Carlson's phone number is 203-304-2499